Creative Planning »

Kymera Therapeutics shares owned by Creative Planning

Quarter-by-quarter ownership of Kymera Therapeutics (KYMR) shares owned by Creative Planning from 13F filings

Historical chart of Creative Planning investment in Kymera Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kymera Therapeutics held by Creative Planning consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kymera Therapeutics by Creative Planning

Quarter filed Position value Share count Share price at filing
2025-09-30 $285k 5.0k 56.60
2024-12-31 $20k 487 40.23

More positions owned by Creative Planning

Ishares Tr Core S&p500 Etf (IVV)
Vanguard Bd Index Fds Total Bnd Mrkt (BND)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Spdr Series Trust Portfolio S&p400 (SPMD)
Ishares Core Msci Emkt (IEMG)
Spdr Index Shs Fds Portfolio Devlpd (SPDW)
Apple (AAPL)
Spdr Series Trust Portfolio S&p500 (SPLG)
Vanguard Scottsdale Fds Int-term Corp (VCIT)
Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Index Fds Total Stk Mkt (VTI)
American Centy Etf Tr Intl Smcp Vlu (AVDV)
Microsoft Corporation (MSFT)
Select Sector Spdr Tr Rl Est Sel Sec (XLRE)
American Centy Etf Tr Us Sml Cp Valu (AVUV)

View all positions for Creative Planning

Top funds holding Kymera Therapeutics

Baker Bros. Advisors
venBio Select Advisor
FMR
BVF
Vanguard Group
Wellington Management Company
Atlas Venture Life Science Advisors
BlackRock
Siren
State Street Corporation
Geode Capital Management
Capital Research Global Investors
Jennison Associates
Driehaus Capital Management
Ubs Global Asset Management Americas

View all funds holding Kymera Therapeutics